A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home

Scandinavian Journal of Public Health

Volumn 32, Issue 5, 2004, Pages 324-332

  Novak, Daniel P ^a   Jonsson, Monica ^a   Karlsson, Roger B ^a   Lindholm, Lars ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Chlamydia trachomatis; cost effectiveness; participation rate; PCR; population screening; postal urine specimen; prevalence

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CLOTRIMAZOLE; DOXYCYCLINE;

ADULT; ARTICLE; ASYMPTOMATIC BACTERIURIA; CANDIDIASIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CARRIER; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTAL MAIL; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SWEDEN; URINALYSIS;

ADULT; CARRIER STATE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; POLYMERASE CHAIN REACTION; POSTAL SERVICE; PREVALENCE; SENSITIVITY AND SPECIFICITY; SWEDEN; URINALYSIS;

EID: 12544257537     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1080/14034940410026282     Document Type: Article

References (33)

1. Mårdh P-A. Chlamydia epidemic, with special emphasis on European perspectives. In: Proceedings of the European Society for Chlamydia research, 1988. Stockholm, Sweden: Almqvist & Wiksell, 1988: 3 - 6.
2. Paavonen J., Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 1999; 5: 433-447.
3. Paavonen J., Lehtinen M. Chlamydial pelvic inflammatory disease. Hum Reprod Update 1996; 2: 519-529.
4. Plummer F.A., Simonsen J.N., Cameron D.W., Ndinya-Achola JO, Kreiss J.K., Gakinya M.N., et al. Cofactors in male - female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163: 233-9.
5. Pimenta J., Fenton K. Recent trends in Chlamydia trachomatis in the United Kingdom and potential for national screening. Eurosurveillance 2001: 81-84.
6. Fenton K.A., Korovessis C., Johnson A.M., McCadden A., McManus S., Wellings K., et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001; 358: 1851-4.
7. Mertz K.J., Levine W.C., Mosure D.J., Berman S.M., Dorian K.J. Trends in the prevalence of chlamydial infections. The impact of community-wide testing. Sex Transm Dis 1997; 24: 169-175.
8. Berglund T. Klamydia, gonorre och syfilis första halvåret [in Swedish]. Smittskydd 2001; 7: 84-85.
9. Novak D., Jonsson M., Boman J., Karlsson R. Is postal screening for C. trachomatis based on urine samples obtained at home a feasible method in Sweden? Eur J Public Health 2003; submitted.
10. Macleod J., Rowsell R., Horner P., Crowley T., Caul E.O., Low N., et al. Postal urine specimens: are they a feasible method for genital chlamydial infection screening? Br J Gen Pract 1999; 49: 455-8.
11. Ostergaard L., Moller J.K., Andersen B., Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. Br Med J 1996; 313: 1186-9.
12. Stephenson J., Carder C., Copas A., Robinson A., Ridgway G., Haines A. Home screening for chlamydial genital infection: is it acceptable to young men and women? Sex Transm Infect 2000; 76: 25-27.
13. Ostergaard L., Andersen B., Olesen F., Moller J.K. Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study. Br Med J 1998; 317: 26-27.
14. Morre S.A., Van Valkengoed I.G., Moes R.M., Boeke A.J., Meijer C.J., Van den Brule AJ Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens. J Clin Microbiol 1999; 37: 3092-6.
15. Drummond M.F., Richardson W.S., O'Brien BJ, Levine M., Heyland D. Users’ guides to the medical literature, XIII: How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997; 277: 1552-7.
16. Genc M., Ruusuvaara L., Mardh P.A. An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA 1993; 270: 2057-2064.
17. Howell M.R., Gaydos J.C., McKee K.T., Jr., Quinn T.C., Gaydos C.A. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis 1999; 26: 519-526.
18. Washington A.E., Arno P.S., Brooks M.A. The economic cost of pelvic inflammatory disease. JAMA 1986; 255: 1735-8.
19. Washington A.E., Johnson R.E., Sanders L.L., Jr. Chlamydia trachomatis infections in the United States. What are they costing us? JAMA 1987; 257: 2070-2.
20. Randolph A.G., Washington A.E. Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis. Am J Public Health 1990; 80: 545-550.
21. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138 (Pt 2): 880-892.
22. Trachtenberg A.I., Washington A.E., Halldorson S. A cost-based decision analysis for Chlamydia screening in California family planning clinics. Obstet Gynecol 1988; 71: 101-8.
23. Schachter J., Sweet R., Grossman M., Landers D., Robbie M., Bishop E. Experience with the routine use of erythromycin for chlamydial infections in pregnancy. N Engl J Med 1986; 314: 276-9.
24. Statistics S. Consumer Price Index 1831 - 2000. Stockholm: SCB, 2001.
25. Russell L.B., Gold M.R., Siegel J.E., Daniels N., Weinstein M.C. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1172-7.
26. Holmes K.K., Johnson D.W., Trostle H.J. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970; 91: 170-4.
27. CMO Main report of CMO's expert advisory committee on Chlamydia trachomatis. London: Dept. of Health; 1998.
28. Macleod J., Smith G.D. Chlamydia screening can have high take-up rates if right methodology is used. Br Med J 1999; 319: 188-9.
29. Novak D., Edman A.C., Jonsson M., Karlsson R.B. The internet, a simple and convenient tool in Chlamydia trachomatis screening of young people. Euro Surveill 2003; 8: 171-6.
30. Scholes D., Stergachis A., Heidrich F.E., Andrilla H., Holmes K.K., Stamm W.E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-6.
31. Edgardh K., Homström U., Bygdeman S., Sandström E., Bäckman M. Asymptomatic teenage girls should be tested for chlamydial infection [in Swedish]. Lakartidningen 1987; 84: 1845-7.
32. Rahm V., Gnarpe A., Rosen G. Chlamydial infection is common among teenage girls who seek contraceptive advice [in Swedish]. Lakartidningen 1986; 83: 615-616.
33. Kaufman R.E., Wiesner P.J. Nonspecific urethritis. N Engl J Med 1974; 291: 1175-7.